当代冠状动脉旁路移植术与多支血管经皮冠状动脉介入治疗的比较
基于美国医疗保险数据库2018至2020年104127例急性冠脉综合征患者,比较孤立性冠状动脉旁路移植术(CABG)与多支血管经皮冠状动脉介入治疗(PCI)的结局。经倾向评分加权调整后,CABG与更低的院内死亡率、3年再入院率、再次血运重建率及更好的3年生存率相关。
要点
- 研究纳入104127例患者,CABG组51389例,多支血管PCI组52738例。
- 倾向评分加权后,CABG组院内死亡率低于PCI组(OR 0.74,P < .001)。
- CABG组3年生存率优于PCI组(HR 0.51,P < .001),再次血运重建更少(HR 0.37,P < .001)。
核心结论
- 当代真实世界数据显示,对于多支血管病变的医疗保险患者,CABG结局优于PCI,为患者管理和政策制定提供纵向数据。
研究设计与样本
- 基于美国医疗保险和医疗补助服务中心数据库,纳入2018至2020年因急性冠脉综合征接受孤立性CABG或多支血管PCI的受益者,共104127例,其中CABG组51389例,多支血管PCI组52738例。
- 采用多水平回归分析、Cox比例风险时间事件模型和逆概率治疗加权倾向评分进行风险调整。
主要发现
- 风险调整前,与PCI组相比,CABG组年龄更轻(72.9岁 vs 75.2岁,P < .001),Elixhauser共病指数更高(5.0 vs 4.2,P < .001),糖尿病更多(48.5% vs 42.2%,P < .001),费用更高(54154美元 vs 33484美元,P < .001),住院时间更长(11.9天 vs 5.8天,P < .001)。
- 逆概率治疗加权倾向评分调整后,与PCI组相比,CABG组院内死亡率更低(OR 0.74,P < .001),3年再入院更少(OR 0.85,P < .001),冠状动脉再次干预更少(HR 0.37,P < .001),3年生存率改善(HR 0.51,P < .001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Interpretation of recent alterations to the guideline priority of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) for multivessel disease contests historical data and practice. To reevaluate contemporary outcomes, a large contemporary analysis was conducted comparing CABG with multivessel PCI among Medicare beneficiaries. METHODS: The United States Centers for Medicare and Medicaid Services database was evaluated all beneficiaries with acute coronary syndrome undergoing isolated CABG or multivessel PCI (2018-2020). Risk adjustment was performed using multilevel regression analysis, Cox proportional hazards time to event models, and inverse probability of treatment weighting propensity scores. RESULTS: A total of 104,127 beneficiaries were identified undergoing CABG (n = 51,389) or multivessel PCI (n = 52,738). Before risk adjustment, compared with PCI, CABG patients were associated with younger age (72.9 vs 75.2 years, P < .001), higher Elixhauser Comorbidity Index (5.0 vs 4.2, P < .001), more diabetes (48.5% vs 42.2%, P < .001), higher cost ($54,154 vs $33,484, P < .001), and longer length of stay (11.9 vs 5.8 days, P < .001). After inverse probability of treatment weighting propensity score adjustment, compared with PCI, CABG was associated with lower hospital mortality (odds ratio, 0.74; P < .001), fewer hospital readmissions at 3 years (odds ratio, 0.85; P < .001), fewer coronary reinterventions (hazard ratio, 0.37; P < .001), and improved 3-year survival (hazard ratio, 0.51; P < .001). CONCLUSIONS: Contemporary real-world data from Medicare patients with multivessel disease reveal that CABG outcomes were superior to PCI, providing important longitudinal data to guide patient care and policy development.
引用
- Mehaffey JH, Hayanga JWA, Kawsara M, et al. Contemporary Coronary Artery Bypass Grafting vs Multivessel Percutaneous Coronary Intervention. Ann Thorac Surg. 2023. PMID: 37353103. doi:10.1016/j.athoracsur.2023.05.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。